Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medipharm Labs Corp
(OP:
MEDIF
)
0.0510
+0.0010 (+2.00%)
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medipharm Labs Corp
< Previous
1
2
3
4
5
Next >
Marijuana Stock Movers For August 9, 2023
↗
August 09, 2023
Via
Benzinga
Topics
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
↗
August 07, 2023
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
↗
August 08, 2023
Via
Benzinga
MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status
↗
August 01, 2023
MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed the US FDA drug API manufacturer inspection at the company's Barrie, Ontario...
Via
Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
↗
August 04, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
↗
July 25, 2023
Via
Benzinga
Cannabis Stock Movers For August 3, 2023
↗
August 03, 2023
Via
Benzinga
Leadership Shake-Ups Across Several Weed Companies: Who Got The Top Jobs?
↗
July 05, 2023
As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the marijuana
Via
Benzinga
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
↗
June 26, 2023
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. (OTCQB: MEDIF) for the commercialization of...
Via
Benzinga
Marijuana Stock Movers For August 2, 2023
↗
August 02, 2023
Via
Benzinga
The Canadian Cannabis Report - Monday, May 22
↗
May 22, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 16 stocks.
Via
Talk Markets
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
↗
May 15, 2023
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth over the past two years and a significant reduction in losses to CA$2.1...
Via
Benzinga
Marijuana Stock Movers For August 1, 2023
↗
August 01, 2023
Via
Benzinga
The Canadian Cannabis Report - Monday, April 14
↗
April 17, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.
Via
Talk Markets
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
↗
April 13, 2023
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow
Via
Benzinga
Cannabis Stock Movers For July 24, 2023
↗
July 24, 2023
Via
Benzinga
The Canadian Cannabis Report - Monday, April 10
↗
April 10, 2023
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks.
Via
Talk Markets
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
↗
March 31, 2023
MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021.
Via
Benzinga
Cannabis Stock Movers For July 20, 2023
↗
July 20, 2023
Via
Benzinga
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
↗
March 22, 2023
MediPharm Labs Corp.
Via
Benzinga
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
↗
March 21, 2023
Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to...
Via
Benzinga
MediPharm Labs To Acquire VIVO Cannabis
↗
December 22, 2022
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc.
Via
Benzinga
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
December 22, 2022
Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets...
Via
Newsfile
Topics
Cannabis
The Canadian Cannabis Report - Monday, Dec. 19
↗
December 19, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, Nov.28
↗
November 28, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, Nov. 21
↗
November 21, 2022
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally
↗
November 14, 2022
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended Sept. 30, 2022.
Via
Benzinga
The Canadian Cannabis Report - Monday, Nov. 14
↗
November 14, 2022
The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, Aug. 29
↗
August 29, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
The Canadian Cannabis Report - Monday, Aug. 15
↗
August 15, 2022
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks.
Via
Talk Markets
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
